CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Major Compliance Challenges Facing The Life Science Industry In 2022

Major Compliance Challenges Facing...

How Pharmaceutical Automation is Revolutionizing Drug Development

How Pharmaceutical Automation is...

Major Challenges In The Evolving Era Of Life Sciences

Major Challenges In The Evolving Era...

Exeevo Brings Innovative Hybrid/Remote Connectivity With Native Integration Into The Omnipresence Customer Relationship Platform, Powered By Microsoft Teams

Exeevo Brings Innovative...

Key Trends in Life Sciences Compliances to Watch out for in 2022

Key Trends in Life Sciences...

Four Proven Pharmaceutical Marketing Strategies to Know

Four Proven Pharmaceutical Marketing...

Key Compliance Challenges Facing Life Science Industry

Key Compliance Challenges Facing Life...

Bruker introduces TOF SCP and TOF Pro 2 for unmatched proteomic dept.

Bruker introduces TOF SCP and TOF Pro...

Major Compliance Challenges Facing The Life Science Industry In 2022

Major Compliance Challenges Facing...

How Pharmaceutical Automation is Revolutionizing Drug Development

How Pharmaceutical Automation is...

Major Challenges In The Evolving Era Of Life Sciences

Major Challenges In The Evolving Era...

Exeevo Brings Innovative Hybrid/Remote Connectivity With Native Integration Into The Omnipresence Customer Relationship Platform, Powered By Microsoft Teams

Exeevo Brings Innovative...

Key Trends in Life Sciences Compliances to Watch out for in 2022

Key Trends in Life Sciences...

Four Proven Pharmaceutical Marketing Strategies to Know

Four Proven Pharmaceutical Marketing...

Key Compliance Challenges Facing Life Science Industry

Key Compliance Challenges Facing Life...

Bruker introduces TOF SCP and TOF Pro 2 for unmatched proteomic dept.

Bruker introduces TOF SCP and TOF Pro...

BioMedion AG Acquires the Compliance Division of arivis AG

Life Sciences Review Life Sciences Review | Tuesday, January 05, 2021
Tweet

BioMedion AG announces the acquisition of arivis AG, a provider of regulatory software and biomedical 3D and big picture data software solutions


FREMONT, CA: A global Compliance Management Software company offering managed content and raw data management solutions for the life science industry, BioMedion AG  announces the acquisition of arivis AG, a provider of regulatory software and biomedical 3D and big picture data software solutions, from the Compliance Division.


BioMedion was founded in 2000 and provided a suite of software utilized in every area of good practice (GxP) where quality standards and regulations are essential. The organization currently serves 115 clients in 15 countries worldwide.


The company has acquired the cloud-based arivis5D content platform that provides users in the pharmaceutical, medical, food, and crop sciences industries a comprehensive, integrated, and computerized approach. BioMedion would have a modern operating system for managed applications operating efficiently on a single platform in controlled environments with the convergence of both parties' technologies.


Following the purchase, neuronOS will be rebranded as the arivis5D content network. By adding new technologies to control multiple digital content types, including instrument data (e.g., scientific images) and digital formats, neuronOS would improve the company's GxP consistency, enforcement, and archiving solutions.


"We are excited to announce the acquisition of the Compliance Division of arivis as we take a major step forward in strengthening our compliance competencies and market position not only in Europe, but also in North America and Asia," said Klaus Pflum, Chairman of the BioMedions Supervisory Board. Matthias Wiedenfels, who facilitated the deal and joins the management board as Chief Corporate Development Officer, added, "The arivis Compliance Division is a perfect match to BioMedions activities in providing next generation software to our customers in highly-regulated industries."


"This strategic acquisition solidifies our position as an integrated software provider with cutting-edge solutions, to leverage innovation amongst the entire life sciences life cycle," said Thorsten Dunker, Chief Operating Officer (COO) of BioMedion.


UniCredit Corporate & Investment Banking operated as a financial analyst. The legal advisors were Osborne Clarke and Ashurst LLP. The parties have agreed that no further financial details of the deal will be disclosed.


Weekly Brief

loading
Top 10 Life Science Compliance Solution Companies - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/biomedion-ag-acquires-the-compliance-division-of-arivis-ag-nwid-220.html